A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

Clinical trial NCT03877055 · COMPLETED

Trial details

NCT number: NCT03877055
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma (MCL)

Start date: 2019-03-13
Primary completion: 2022-10-07
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.